The Vexing Problem of HFpEF Therapeutics: Inching Toward Success

JACC Heart Fail. 2021 May;9(5):371-373. doi: 10.1016/j.jchf.2021.02.005.

Authors

Sheldon E Litwin¹, Michael R Zile²

Affiliations

¹ Division of Cardiology, Medical University of South Carolina, USA; Division of Cardiology, Ralph H. Johnson Veterans Affairs Medical Center, Charleston, South Carolina, USA. Electronic address: litwins@musc.edu.
² Division of Cardiology, Medical University of South Carolina, USA; Division of Cardiology, Ralph H. Johnson Veterans Affairs Medical Center, Charleston, South Carolina, USA.

PMID: 33926730
DOI: 10.1016/j.jchf.2021.02.005

No abstract available

Keywords: HFpEF; diastolic function; inotrope; pulmonary hypertension; vasodilator.

Publication types

Editorial
Comment

MeSH terms

Heart Failure* / therapy
Humans
Hypertension, Pulmonary*
Stroke Volume
Ventricular Function, Left